Search for other papers by Tetsuya Mizokami in
Google Scholar
PubMed
Search for other papers by Katsuhiko Hamada in
Google Scholar
PubMed
Search for other papers by Tetsushi Maruta in
Google Scholar
PubMed
Search for other papers by Kiichiro Higashi in
Google Scholar
PubMed
Search for other papers by Junichi Tajiri in
Google Scholar
PubMed
radioactive iodine therapy in adolescent patients with Graves' disease. Int J Pediatr Endocrinol 2011;2011:14. 10.1186/1687-9856-2011-14 22060749 6 Tajiri J: Radioactive iodine therapy for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 2006
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Search for other papers by Raza Hussain in
Google Scholar
PubMed
recurrence classification at baseline [ 1 ] and response to initial therapy 6-24 months after radioactive iodine (RAI) ablation [ 2 ], the more aggressive subset of patients should theoretically be identified in whom the chance of developing radioiodine
Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
for Treatment of Thyroid Tumor [ 5 ]. First, we initiated TSH-suppressive therapy with levothyroxine after the surgery. Second, he received radioactive iodine ablation. One year after the initial treatment, the patient displayed a serum Tg level of 4
Search for other papers by Ian D Hay in
Google Scholar
PubMed
Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed
Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed
period, negative whole-body scanning (WBS) with radioactive iodine (RAI) and, in later years, non-stimulable TSH responses to thyrotropin-releasing hormone were considered as the ‘gold standards’ for adequate PTC treatment ( 8 , 9 , 10 , 11
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Department of Pedagogical, Curricular and Professional Studies, Faculty of Education, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Simon Skau in
Google Scholar
PubMed
Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
were initially treated with ATD and when necessary with surgery. At 15 months, 36% had undergone thyroidectomy, one patient was treated with radioactive iodine, 47% were receiving ATD, and 17% had no treatment and were in remission. Due to the high
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
F Yang SP Bulzico DA Corbo R Vaisman M & Tuttle RM . Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine . Journal of Clinical Endocrinology and Metabolism 2016 101 2692 – 2700
Search for other papers by Satoshi Koyama in
Google Scholar
PubMed
Search for other papers by Naritomo Miyake in
Google Scholar
PubMed
Search for other papers by Kazunori Fujiwara in
Google Scholar
PubMed
Search for other papers by Tsuyoshi Morisaki in
Google Scholar
PubMed
Search for other papers by Takahiro Fukuhara in
Google Scholar
PubMed
Center for Head and Neck Surgery, Kusatsu General Hospital, Kusatsu, Japan
Search for other papers by Hiroya Kitano in
Google Scholar
PubMed
Search for other papers by Hiromi Takeuchi in
Google Scholar
PubMed
received no treatment prior to lenvatinib; the remaining patient (case 2) had undergone total thyroidectomy and radioactive iodine treatment prior to receiving lenvatinib. The 4 patients except case 1 were diagnosed with unilateral recurrent laryngeal nerve
Search for other papers by Anne-Sophie Bertrand in
Google Scholar
PubMed
Search for other papers by Antoine Iannessi in
Google Scholar
PubMed
Search for other papers by Isabelle Peyrottes in
Google Scholar
PubMed
Search for other papers by Alexis Lacout in
Google Scholar
PubMed
Search for other papers by Antoine Thyss in
Google Scholar
PubMed
Search for other papers by Pierre-Yves Marcy in
Google Scholar
PubMed
to be published: all authors. References 1 Rosario PW , Mourão GF , Calsolari MR . Efficacy of adjuvant therapy with 3.7 GBq radioactive iodine in intermediate-risk patients with ‘higher risk features’ and predictive value
Search for other papers by Laura Moss in
Google Scholar
PubMed
Search for other papers by Catrin Cox in
Google Scholar
PubMed
Search for other papers by Jonathan Wadsley in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Search for other papers by Maralyn Druce in
Google Scholar
PubMed
Search for other papers by Neil Tolley in
Google Scholar
PubMed
Search for other papers by Kathryn Graham in
Google Scholar
PubMed
Search for other papers by Sarah Jefferies in
Google Scholar
PubMed
Search for other papers by Lydia Fresco in
Google Scholar
PubMed
Search for other papers by Suganya Sivabalasingham in
Google Scholar
PubMed
Search for other papers by Alistair Balfour in
Google Scholar
PubMed
Search for other papers by Chris Hurt in
Google Scholar
PubMed
assess thyroid cancer issues and EORTC QLQ-GINET21 [ 7 ] which assesses issues relevant to neuroendocrine tumours. The City of Hope Scale was amended by removing four questions related to radioactive iodine treatment which is not relevant to the study
Department of Endocrinology, Portuguese Institute of Oncology, Lisbon, Portugal
Search for other papers by Mafalda Marcelino in
Google Scholar
PubMed
Search for other papers by Pedro Marques in
Google Scholar
PubMed
Search for other papers by Luis Lopes in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Search for other papers by João Jácome de Castro in
Google Scholar
PubMed
. Endocr J 2005;52:309-316. 10.1507/endocrj.52.309 16006725 3 Uludag M, Yetkin G, Citgez B, Isgor A, Basak T: Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer. Hormones 2008